Mirimus
Biotechnology, 760 Parkside Ave, Brooklyn, New York, 11226, United States, 51-200 Employees
Phone Number: 92********
Who is MIRIMUS
Diagnostics We build innovative diagnostic and monitoring tools that empower people to make better decisions about their health. Drug Discovery We translate early-stage research into cust...
Read More
-
Headquarters: 760 Parkside Ave, Brooklyn, New York, 11226, United States
-
Date Founded: 2010
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
-
CEO:
Mirimus Inc.
Email
Phone
Industry: Biotechnology
SIC Code: 8731
Mirimus Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Mirimus
Answer: Mirimus's headquarters are located at 760 Parkside Ave, Brooklyn, New York, 11226, United States
Answer: Mirimus's phone number is 92********
Answer: Mirimus's official website is https://mirimus.com
Answer: Mirimus's revenue is $25 Million to $50 Million
Answer: Mirimus's SIC: 8731
Answer: Mirimus has 51-200 employees
Answer: Mirimus is in Biotechnology
Answer: Mirimus contact info: Phone number: 92******** Website: https://mirimus.com
Answer: Diagnostics We build innovative diagnostic and monitoring tools that empower people to make better decisions about their health. Drug Discovery We translate early-stage research into customized RNAi and CRISPR Cas9 animal and cell models to accelerate drug development. Therapeutics We identify and validate new drug targets, unleashing the commercial potential of RNAi to benefit people on a global scale. Established in 2010 to harness the power of RNAi and genetic engineering technologies developed by our founders in the labs of the worlds leading experts at Cold Spring Harbor Laboratory, Howard Hughes Medical Institute, and Harvard Medical School, Mirimus creates innovative research and clinical technologies to address health issues on a global scale. Today, Mirimus markets multiple unique and high-value drug discovery and diagnostic products and services, and is advancing a pipeline of therapeutic candidates in partnership with leading biopharma companies to create novel high-impact health care solutions that benefits society on a global scale. Mirimus ability to leverage its cutting-edge science and proprietary technology platforms to rapidly create new, affordable technology and products at scale is core to the way we work. We embrace diversity and creativity and have a proven track record of innovative problem solvingwhich led to our recognition as a $1M grand prize winner of the XPRIZE competition by developing a radically affordable, rapid, non-invasive methodology for mass COVID-19 testingdriving us to make better drugs and detect disease earlier. At Mirimus, our ingenuity, respect for our colleagues ideas and creativity, executional agility, and a commitment to global health equity combine to create a unique culture of innovation that delivers measurable progress.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month